Mastocytosis is a heterogeneous disorder characterized by the proliferation and accumulation of mast cells (MCs) in the skin, bone marrow, and other tissues [1] . Owing to massive MC activation and release of mediators, patients with mastocytosis may experience systemic symptoms, including hypotension and shock, flushing, headache, abdominal pain, and diarrhea. Serum baseline tryptase correlates with the total MC count and burden and is increased in many patients. In mastocytosis, MC can be activated by various stimuli, including hymenoptera venom, through an IgE-mediated mechanism [2] . There are several reports on patients with systemic mastocytosis (SM) and a history of severe sting reactions, but with negative venom-specific IgE and skin test results [3] . In such cases, other diagnostic methods, such as the basophil activation test (BAT), can prove useful [4] . Reports about the usefulness of BAT in patients with negative specific IgE (sIgE) results show varying results. Some studies find that BAT does not provide useful information in this kind of patient [5, 6] , while other papers report the opposite [7, 8] . Interestingly, different methods for identifying basophils were used in the studies, and negative results were obtained in those using chemokine CC receptor type 3 (CCR3) [5, 6] , whereas positive results were obtained in those using the IL3 receptor (CD123) in conjunction with HLA-DR [7] or CD45 and IgE [8] .
We discuss the usefulness of BAT in 2 patients with systemic reactions after wasp sting and mastocytosis.
We studied 2 men aged 53 and 64 years (patient 1 and patient 2, respectively) with systemic reactions after wasp sting. Patient 1 presented dizziness, vomiting, dyspnea, and loss of consciousness 25 minutes after the sting, and patient 2 experienced flushing and loss of consciousness 10 minutes after the sting. Neither experienced cutaneous symptoms. Both had high tryptase values (>20 μg/mL) (Table) 1 month after the reactions.
is a confounding factor that is overrepresented in ß-lactamallergic patients and that the previously described associations could have been due to atopy.
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positive results for Vespula and Polistes were obtained using IgE, while a lower value for Vespula and a negative result for Polistes were obtained using the CCR3 molecule.
Both patients were diagnosed with SM, with an anaphylactic reaction after wasp sting and negative results in the classic diagnostic tests for hymenoptera venom allergy (HVA), and had a positive result in BAT against hymenoptera venom. In the absence of classic diagnostic tests, this cellular test showed that the reaction was mediated by IgE and thus enabled prescription of venom immunotherapy. Venom-specific IgE cannot be detected in 5%-10% of patients with mastocytosis and HVA [3] , because of increased absorption of circulating IgE by the large amount of mast cells, with consequent low circulating levels of sIgE that prevent appropriate detection with classic tests. This may also be responsible for the negative results in the skin tests.
BAT is based on exposure of specific antigens against sIgE bound to FcεRI receptors on the surface of basophils. Specific antigen-antibody binding induces degranulation of basophils, and constituent molecules in the membrane of basophil granules such as CD63 or CD203 are expressed in the cell membrane and can be detected by the antibodies used in the test. The large number of mast cells present in patients with SM can reduce the presence of IgE in the membrane of basophils. In fact, BAT has shown good results in patients with HVA without mastocytosis under the same conditions and with the same dose of allergen [10] . Various flow cytometry-based methods can be used to identify basophils in whole blood (eg, IgE, CCR3, CD203c/CD123/HLA-DR, and CD45/CD123/HLA-DR). Interestingly, in the studies that show little or no validity for the BAT assay in patients with SM and negative sIgE, basophils are recognized by means of the eotaxin-3 receptor (CCR3) [5, 6] . In this case, it is probably basophils with low amounts of IgE on their surface that are selected, thus explaining the poor results of the BAT. Under this assumption, detecting basophils in BAT with an anti-IgE antibody would clearly improve the results and make it possible to avoid false negatives. In our study, a sample was tested in parallel using IgE and CCR3 to identify basophils, and we found lower values using CCR3. Even with Polistes, the results changed from positive to negative (<5%) when basophils were identified by CCR3. The patient was receiving venom immunotherapy when these second BATs were performed, although this did not influence the results, as the tests were performed in parallel, with the same blood sample, and at the same time. Adequate selection of the molecule used for the identification of basophils in BAT could ensure optimal results in patients with SM and HVA. Under these premises, BAT may be an adequate tool for assessing patients with SM and systemic reactions due to hymenoptera venom.
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Both patients had a Red Española de Mastocitosis (REMA [Spanish Network on Mastocytosis]) score >2 [9] , which was suggestive of clonal mast cell disorder, and were diagnosed with indolent SM after bone marrow biopsy at Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) according to World Health Organization (WHO) criteria. sIgE against whole venom and components was determined several months after the reaction. Intradermal tests (IDT) with Apis mellifera, Vespula species, and Polistes dominula venoms up to 1 µg/mL were also performed in patient 1. The results of sIgE and IDT were negative (Table) .
In order to determine sensitization to venom, BAT was performed as previously described [10] . Basophils were detected initially using an anti-IgE monoclonal antibody, and the degranulated basophils were detected by expression of CD63 on the surface of the cells. The test was carried out against venom from P dominula and Vespula species at a final concentration of 1 μg/mL (Pharmalgen ALK-Abelló). BAT results were positive (>15% of activated basophils) in both patients for both venoms (Table) , thus enabling identification of sensitization and prescription of venom immunotherapy.
In patient 1, we repeated BAT 6 months later using 2 different membrane molecules (IgE and CCR3) to identify basophils. These tests were performed after 6 months of immunotherapy with Vespula and Polistes venoms. As shown in the table, The prevalence of Cupressaceae-Taxodiaceae pollen allergy has increased in the Mediterranean area in recent years [1, 2] . In order to assess the impact of this allergy in our area, we carried out a prospective, cross-sectional study at Terrassa Hospital, Vallés Occidental, Barcelona, Spain. The hospital is located in an urban district with more than 800 000 inhabitants. The objectives of this study were as follows: (1) to determine the annual incidence of sensitization to Cupressaceae pollen in the catchment population; (2) to describe the clinical characteristics and the molecular profile of sensitization; (3) to test the diagnostic performance of pollen extracts in skin prick testing (SPT), serum sIgE testing, and nasal provocation testing (NPT) for the diagnosis of cypress allergy.
After signing the informed consent document, patients with symptoms suggestive of respiratory allergy and a positive SPT result to ≥1 of the 3 extracts of cypress pollen tested (Cupressus sempervirens, Cupressus arizonica, and Juniperus ashei [Stallergenes]) were included in the study between February 1, 2010 and January 31, 2011. Demographic and clinical data were collected. Serum sIgE to the same 3 species (ImmunoCAP) and to molecular allergens (ImmunoCAP ISAC) was measured. NPT was performed with a J ashei extract (Stallergenes).
Symptoms and medication use were recorded in a diary, and cypress pollen concentrations were provided by Xarxa Aerobiologica de Catalunya (Aerobiology Network of Catalonia). A positive SPT result with Cupressaceae pollen and concordant respiratory symptoms were considered the gold standard. The statistical analysis was performed using SAS 9.4 and SAS Enterprise 6.1.
A total of 1278 new patients were evaluated. The incidence of sensitization to Cupressaceae pollen assessed by SPT was 15.1%, which decreased to 13.7% and 11% when the assessment was based on positive sIgE to complete extract and individual allergens, respectively.
The characteristics of Cupressaceae pollen-sensitized patients and the control group (sensitized to other aeroallergens) are shown in the Table, which highlights statistically significant 
